Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014. - Wikidata - wikimedia - TriplyDB

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.

http://www.wikidata.org/entity/Q35183700

about

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.

http://www.wikidata.org/entity/Q35183700

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.

@ast

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.

@en

type

label

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.

@ast

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.

@en

prefLabel

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.

@ast

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.

@en

P1433

Q35183700-B6EFBD14-31B7-40B4-9F48-55B744E423B9

P1476

Q35183700-77C00719-2885-47C2-AD7B-3E5D6DDCBF56

P2093

Q35183700-288F1330-4E8F-4B78-B465-015C3CECCC8C

Q35183700-2942F399-29FE-46E7-AA5E-7B66363B7B29

Q35183700-585256BE-D304-4F70-92F8-A26392E2FA24

Q35183700-74A2F070-BFDE-4664-9DB7-6D380FE2FF5E

Q35183700-7A7A7D12-74DA-45D3-8740-483A9AACC211

Q35183700-8648D5C5-C1F5-44FD-AD6B-087D1D6AE9C4

Q35183700-97B8A097-DC58-4D63-81E1-A49778E5AC5B

Q35183700-A0B2D3DF-618A-43C1-885E-0DC5616652D2

Q35183700-B84AEAF1-E65B-4E8D-AE50-98956B7F9105

Q35183700-BD720992-B545-43D7-90F7-A153876397D1

P2860

Q35183700-0F5DE483-9EA4-4466-8F82-2F371CCED5D5

Q35183700-1CAADCFB-8FB0-4A9B-845E-4E0FAEB38369

Q35183700-1D4018D2-2685-40DF-A276-416F40C9C427

Q35183700-34EDC0D2-BC45-4678-8F92-1A6A99BCF4D4

Q35183700-3CC7B4C2-B42E-4DEA-B085-6540CAC08641

Q35183700-529EE5C7-0F72-4059-BAE0-3A3D057E08D8

Q35183700-B69EC83A-A608-4DC7-B854-2C209E5EF262

Q35183700-F2DD1A64-8D32-4D62-82F9-218D2671BA5A

Q35183700-F3FC33C9-E2FB-4C8A-A8B8-3D51A94F3737

P304

Q35183700-607906AD-621F-45BC-95D3-901770554E93

P31

Q35183700-0BF4CF8B-C60F-41B1-A7E8-DF0D8BC6A90C

P433

Q35183700-CFF4D836-1312-4288-BA33-60D5E1FD9E97

P478

Q35183700-2137EF68-595B-47A1-BCAC-2289D461EC83

P50

Q35183700-E09FB0EC-9ACE-487B-8469-A91935B420A0

P577

Q35183700-90A1D0AF-86DD-4BC9-80AA-54367F558D0B

P698

Q35183700-D8D5D766-C076-4AD5-B9E3-A08D0A695AA5

P932

Q35183700-6CDF98FF-91E3-4239-B069-F617CB38A9F0

P1433

Saudi Medical Journal

P1476

Saudi Oncology Society clinical management guideline series. Pancreatic cancer 2014

@en

P2093

Abdullah A Alsharm

http://www.w3.org/2001/XMLSchema#string

Ahmed S Al-Shehri

http://www.w3.org/2001/XMLSchema#string

Ali H Aljubran

http://www.w3.org/2001/XMLSchema#string

Ali M Alzahrani

http://www.w3.org/2001/XMLSchema#string

Ashwaq A Al Olayan

http://www.w3.org/2001/XMLSchema#string

Jamal E Zekri

http://www.w3.org/2001/XMLSchema#string

Magdy S Kandil

http://www.w3.org/2001/XMLSchema#string

Mohammed M Rahal

http://www.w3.org/2001/XMLSchema#string

Monther A Kabbani

http://www.w3.org/2001/XMLSchema#string

Mosa A Fagih

http://www.w3.org/2001/XMLSchema#string

P2860

Perioperative mortality for pancreatectomy: a national perspective

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.

Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review.

A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.

P304

1534-1537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Shouki Bazarbashi

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25491225

http://www.w3.org/2001/XMLSchema#string

P932

4362172

http://www.w3.org/2001/XMLSchema#string